Lynette C.Y. Chee, MBBS, PhD, FRACP, FRCPA1, David M. Ross, MBBS, PhD, FRACP, FRCPA2*, Thomas Cluzeau, MD, PhD3, Shuhying Tan, FRACP, FRCPA, MBBS4*, Aristoteles Giagounidis5, David Valcarcel, MD, PhD6, Montserrat Arnan, MD, PhD7*, Maria Diez-Campelo, MD, PhD8*, Christine Graham, PhD9*, Allie McGinty9*, Miranda Ross, BS9*, Suresh Bobba9*, Wei Feng9*, Ying Jiang9*, Montagu Hankin, MSc9*, Christopher Rovaldi9*, Simon Cooper, MBBS9, Dena Grayson, MD, PhD9* and Jen L. Salstrom, MD, PhD9
1Department of Clinical Haematology and Bone Marrow Transplant Service, The Royal Melbourne Hospital, Parkville, Australia
2Department of Haematology, Flinders Medical Centre and University, Adelaide, SA, Australia
3Nice University Hospital, Nice, Provence Alpes Cote d'Azur, France
4St. Vincent's Institute of Medical Research, East Melbourne, Vic, AUS
5Dept. Oncology, Hematology and Palliative Care, Marienhospital Düsseldorf, Düsseldorf, Germany
6Department of Hematology, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain
7Institut Català d’Oncologia , Hospital Duran i Reynals, Barcelona, Spain
8University Hospital of Salamanca, Salamanca, Spain
9Keros Therapeutics, Lexington, MA